Naoaki Sakata Selected Research

Naoaki Sakata Research Topics

Disease

17	Neoplasms (Cancer) 01/2020 - 01/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 02/2018 - 10/2011
8	Diabetes Mellitus 10/2022 - 04/2006
8	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2002
6	Neoplasms, Cystic, Mucinous, and Serous 01/2014 - 01/2007
5	Inflammation (Inflammations) 04/2022 - 01/2015
4	Pancreatitis 04/2022 - 01/2008
4	Hypoxia (Hypoxemia) 01/2014 - 03/2009
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2019 - 12/2011
3	Chronic Pancreatitis 02/2019 - 11/2010
3	Hemorrhage 02/2019 - 09/2012
3	Cholangiocarcinoma 12/2018 - 11/2011
2	Ischemia 01/2021 - 03/2009
2	Hyperglycemia 02/2019 - 05/2007
2	Hypoglycemia (Reactive Hypoglycemia) 02/2019 - 02/2012
2	Shock 02/2019 - 02/2012
2	Stomach Neoplasms (Stomach Cancer) 10/2018 - 01/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 02/2018 - 11/2017
2	Breast Neoplasms (Breast Cancer) 01/2017 - 02/2007
2	Arteriovenous Malformations (Arteriovenous Malformation) 09/2013 - 01/2008
1	Fibrosis (Cirrhosis) 04/2022
1	Edema (Dropsy) 04/2022
1	Diabetic Foot 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Ulcer 01/2022
1	Chronic Limb-Threatening Ischemia 01/2021
1	Peripheral Arterial Disease 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 08/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2020
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 02/2019
1	Pain (Aches) 02/2019
1	Lymphatic Metastasis 10/2018
1	Autoimmune Diseases (Autoimmune Disease) 05/2018
1	Adenocarcinoma 11/2017

Drug/Important Bio-Agent (IBA)

7	Insulin (Novolin)FDA Link 02/2019 - 01/2009
7	Gemcitabine FDA Link 12/2017 - 10/2011
4	Therapeutic UsesIBA 01/2022 - 07/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022 - 11/2010
3	Pharmaceutical PreparationsIBA 01/2017 - 02/2007
3	MucinsIBA 01/2014 - 11/2007
3	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 05/2007
2	EnzymesIBA 04/2022 - 01/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 04/2022 - 02/2012
2	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 11/2011
2	Blood Glucose (Blood Sugar)IBA 02/2019 - 04/2006
2	Proteins (Proteins, Gene)FDA Link 05/2018 - 01/2017
2	130-nm albumin-bound paclitaxelIBA 12/2017 - 11/2017
2	BilirubinIBA 12/2017 - 12/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 02/2007
2	Hematoxylin (Haematoxylon)IBA 11/2010 - 07/2009
2	Eosine Yellowish-(YS) (Eosin)IBA 11/2010 - 07/2009
1	Alprostadil (Muse)FDA LinkGeneric 04/2022
1	ImmunosorbentsIBA 04/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2022
1	Vascular Endothelial Growth FactorsIBA 01/2022
1	InflammasomesIBA 10/2020
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 10/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2020
1	bicalutamide (Casodex)FDA LinkGeneric 01/2020
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2019
1	Complement System Proteins (Complement)IBA 02/2019
1	Oncogene Proteins (Oncogene Protein)IBA 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	Ligases (Synthetase)IBA 12/2018
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 12/2018
1	UbiquitinIBA 12/2018
1	Prostaglandins AIBA 10/2018
1	DesminIBA 12/2017
1	Alkaline PhosphataseIBA 12/2017
1	TransferasesIBA 12/2017
1	VimentinIBA 12/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	Steroid 12-alpha-Hydroxylase (CYP8B1)IBA 01/2017
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2017

Therapy/Procedure

15	Therapeutics 10/2022 - 02/2007
12	Pancreatectomy 02/2019 - 01/2007
11	Islets of Langerhans Transplantation 10/2022 - 03/2009
8	Drug Therapy (Chemotherapy) 02/2018 - 02/2007
6	Transplantation 01/2022 - 04/2006
6	Neoadjuvant Therapy 11/2016 - 11/2011
5	Pancreaticoduodenectomy 11/2016 - 01/2007
2	Heterologous Transplantation (Xenotransplantation) 01/2022 - 01/2021
2	Pancreaticojejunostomy 02/2019 - 11/2010
2	Autologous Transplantation 09/2013 - 09/2012
2	Laparoscopic Cholecystectomy 03/2013 - 01/2002
2	Pancreas Transplantation 05/2007 - 04/2006
1	Intravenous Injections 04/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2020
1	Craniotomy 01/2020
1	Combined Modality Therapy 01/2020
1	Operative Time 02/2019
1	Lasers (Laser) 05/2018
1	Ovariectomy (Oophorectomy) 02/2018
1	Metastasectomy 12/2017
1	Radiotherapy 12/2017
1	Aftercare (After-Treatment) 12/2017
1	Laparotomy 11/2017